Psychopharmacology and Psychiatry Updates

A podcast by Psychopharmacology Institute

Categorie:

243 Episodio

  1. ADHD Meds for Preschoolers: Lisdexamfetamine

    Pubblicato: 11/7/2023
  2. Using Ginkgo Biloba in Children

    Pubblicato: 6/7/2023
  3. Examining COVID's Lasting Effects in Psychiatry

    Pubblicato: 1/7/2023
  4. Beyond SSRIs: Antipsychotic Augmentation in OCD

    Pubblicato: 26/6/2023
  5. Overcoming Barriers to Metabolic Monitoring in Youth Treated With SGAs

    Pubblicato: 21/6/2023
  6. Exploring Outcomes and Strategies in OCD Treatment After the First Trial

    Pubblicato: 16/6/2023
  7. Diving Into the APA Annual Meeting: Highlights and Insights!

    Pubblicato: 11/6/2023
  8. Exploring the Intriguing World of Microdosing Psilocybin

    Pubblicato: 6/6/2023
  9. SSRIs for OCD: A Closer Look at First-Line Treatment

    Pubblicato: 1/6/2023
  10. Exploring Nonstimulant Treatments for ADHD

    Pubblicato: 27/5/2023
  11. Complexities of OCD Treatment: Comorbidities and Other Considerations

    Pubblicato: 22/5/2023
  12. Lamotrigine and Lithium Combination Therapy for Rapid Cycling Bipolar Disorder

    Pubblicato: 17/5/2023
  13. Melatonin and Secretin for Youth

    Pubblicato: 12/5/2023
  14. Tackling NSSI in Adolescents: Can Medications Help?

    Pubblicato: 7/5/2023
  15. D-Cycloserine for Anxiety Disorders in Youth

    Pubblicato: 2/5/2023
  16. Clinical Significance of Antidepressants for the Treatment of Acute Depression

    Pubblicato: 27/4/2023
  17. Memantine: Potential Indications in Youth

    Pubblicato: 22/4/2023
  18. Low-Dose Olanzapine for Anorexia Nervosa

    Pubblicato: 17/4/2023
  19. Naltrexone in Youth: Exploring Potential Applications and Cautions

    Pubblicato: 12/4/2023
  20. Lamotrigine Titration: Slowing Down for Safer Treatment

    Pubblicato: 7/4/2023

6 / 13

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site